New hope for tots with painful feeding disorder
NCT ID NCT07112378
Summary
This study is testing an experimental drug called dupilumab in very young children (6 months and up) who have active eosinophilic esophagitis (EoE), a condition that causes painful inflammation in the food pipe and makes eating difficult. The main goal is to see if the drug is safe and effective at reducing inflammation when given for 24 weeks. Researchers will also measure how much of the drug gets into the blood and check for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS (EOE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GI Care for Kids LLC
RECRUITINGAtlanta, Georgia, 30342, United States
-
Phoenix Childrens Hospital
RECRUITINGPhoenix, Arizona, 85016, United States
-
University of North Carolina, Bioinformatics Building
RECRUITINGChapel Hill, North Carolina, 27599, United States
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22908, United States
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.